Published date: 13 December 2019
Last edited date: 5 November 2020
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Albumin - 33141540
Location of contract
England, Northern Ireland, Isle of Man, Channel Islands
Value of contract
£31,000,000
Procurement reference
CM/PHS/17/5549
Published date
13 December 2019
Approach to market date
13 November 2020
Contract start date
1 May 2021
Contract end date
31 October 2022
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Human Albumin and Human Anti-D Immunoglobulin
More information
Spend profile
| Financial year | Budget |
|---|---|
| 2021/2022 | £18,944,444 |
| 2022/2023 | £12,055,556 |
About the buyer
Contact name
Jennifer Tierney
Address
Commercial Medicines Unit - NHS England
2nd Floor Rutland House
Runcorn
WA7 2ES
England
Share this notice
Approach to market date: 13 November 2020
All content is available under the
